Efzofitimod is an Immunomodulator of Myeloid Cell Function and Novel Therapeutic Candidate for Interstitial Lung Diseases

• Company About Us Leadership Team Board of Directors Advisors Contact

• Our Science Extracellular t RNA Synthetase Biology Intellectual Property Publications, Posters and Presentations

• R&D Pipeline Efzofitimod Research Programs Pangu

• Patients Clinical Trials About Pulmonary Sarcoidosis About SSc-ILD EFZO-CONNECT ™ Expanded Access Policy

• Careers Working at aTyr Career Opportunities

• Investors and Media Corporate Governance Board of Directors Board Committees News Releases SEC Filings Stock Information Analyst Coverage Investor Alerts Events and Webcasts Media

• Privacy Policy

• About Us

• Leadership Team

• Board of Directors

• Advisors

• Contact

• Extracellular t RNA Synthetase Biology

• Intellectual Property

• Publications, Posters and Presentations

• Pipeline

• Efzofitimod

• Research Programs

• Pangu

• Clinical Trials

• About Pulmonary Sarcoidosis

• About SSc-ILD

• EFZO-CONNECT ™

• Expanded Access Policy

• Working at aTyr

• Career Opportunities

• Corporate Governance Board of Directors Board Committees

• News Releases

• SEC Filings

• Stock Information

• Analyst Coverage

• Investor Alerts

• Events and Webcasts

• Media

• Board of Directors

• Board Committees